摘要
日益增加的多药耐药性已威胁公众健康。多药耐药外排泵的过度表达是耐药菌耐药的主要机制之一。由于抗菌药物的主动外排起着重要的作用,在调解耐药性的细菌,外排泵的抑制似乎是一种恢复抗菌效力的有效方法。近年来,为了解决由外排泵介导的多药耐药这一严重的问题,已经发现和测试了大量的外排泵抑制剂,包括天然产物,抗生素和合成分子。本综述主要介绍了在寻找能够抑制革兰氏阳性和革兰阴性菌外排泵的新分子最近取得的成就,特别强调了金黄色葡萄球菌、铜绿假单胞菌和AcrAB-TolC肠杆菌外排泵的天然和合成抑制剂。并主要关注于其作用机制、构效关系及与临床抗生素的协同作用。
关键词: 多药耐药,外排泵,泵抑制剂,NorA,MexAB-OprM,AcrAB-TolC
图形摘要
Current Drug Targets
Title:Efflux Pump Inhibitors: A Novel Approach to Combat Efflux-Mediated Drug Resistance in Bacteria
Volume: 17 Issue: 6
Author(s): Yinhu Wang, Henrietta Venter and Shutao Ma
Affiliation:
关键词: 多药耐药,外排泵,泵抑制剂,NorA,MexAB-OprM,AcrAB-TolC
摘要: The increasing multi-drug resistance has become a major threat to the public health. Overexpression of multidrug efflux pumps is one of the major mechanisms of drug resistance in bacteria. Since active efflux of antibacterial agents plays a significant role in mediating drug resistance in bacteria, the inhibition of efflux pumps appears to be a promising strategy to restore antibacterial potency. In recent years, in order to address this grave problem of multiple drug resistance mediated by efflux pump, a large number of efflux pump inhibitors have been discovered and tested, including natural products, antibiotics and synthetic molecules. This review mainly describes recent achievements in the search for new molecules that are able to inhibit efflux pumps in both Gram-positive and Gram-negative bacteria, in particular emphasis on natural and synthetic inhibitors of the NorA efflux pump in Staphylococcus aureus, MexAB-OprM efflux pump in Pseudomonas aeruginosa, and AcrAB-TolC efflux pump in Enterobacteriaceae, giving special attention to their mechanisms of action, structureactivity relationships and synergetic effect with clinically available antibiotics.
Export Options
About this article
Cite this article as:
Yinhu Wang, Henrietta Venter and Shutao Ma , Efflux Pump Inhibitors: A Novel Approach to Combat Efflux-Mediated Drug Resistance in Bacteria , Current Drug Targets 2016; 17 (6) . https://dx.doi.org/10.2174/1389450116666151001103948
DOI https://dx.doi.org/10.2174/1389450116666151001103948 |
Print ISSN 1389-4501 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-5592 |
![](/images/wayfinder.jpg)
- Author Guidelines
- Bentham Author Support Services (BASS)
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Micro-/Nano-Scale Biointerfaces, Mechanical Coupling and Cancer Therapy
Current Topics in Medicinal Chemistry Immunomodulatory Activity of Garlic
Current Immunology Reviews (Discontinued) Decreased Expression and Altered Methylation of Syncytin-1 Gene in Human Placentas Associated with Preeclampsia
Current Pharmaceutical Design Molecular Targets of Mesalazine in Colorectal Cancer
Current Cancer Therapy Reviews Renoprotection and Mechanisms of Erythropoietin and Its Derivatives Helix B Surface Peptide in Kidney Injuries
Current Protein & Peptide Science The Role of LEF/TCF Factors in Neoplastic Transformation
Current Molecular Medicine Emerging Concepts in the Analysis of Mitochondrial Genome Instability
Current Genomics New Issues for Copper-64: from Precursor to Innovative Pet Tracers in Clinical Oncology
Current Radiopharmaceuticals Current and Emerging Systemic Therapy in Gastro-Esophageal Cancer “The Old and New Therapy for Metastatic Disease, The Role of Adjuvant and Neoadjuvant Therapy for Localized Disease”
Current Clinical Pharmacology miR-203 Suppresses the Proliferation and Metastasis of Hepatocellular Carcinoma by Targeting Oncogene ADAM9 and Oncogenic Long Non-coding RNA HULC
Anti-Cancer Agents in Medicinal Chemistry Histone Deacetylases as Targets for Dietary Cancer Preventive Agents: Lessons Learned with Butyrate, Diallyl Disulfide, and Sulforaphane
Current Drug Targets Smart Drug-Delivery Systems for Cancer Nanotherapy
Current Drug Targets Folate Receptor Targeted Liposomes
Drug Design Reviews - Online (Discontinued) State of Art and Recent Developments of Anti-Cancer Strategies Based on TRAIL
Recent Patents on Anti-Cancer Drug Discovery Insights into a Critical Role of the FOXO3a-FOXM1 Axis in DNA Damage Response and Genotoxic Drug Resistance
Current Drug Targets Pharmaceutical Strategies Enhancing Cell Penetration Efficiencies of Non-Viral Gene Delivery Systems
Current Gene Therapy Mitochondrial Drug Targets in Cell Death and Cancer
Current Pharmaceutical Design COX Selectivity and Animal Models for Colon Cancer
Current Pharmaceutical Design Beyond the Selective Inhibition of Histone Deacetylase 6
Mini-Reviews in Medicinal Chemistry Gene Expression Significance in Personalized Medicine of Non-small Cell Lung Cancer and Gene Expression Analyzing Platforms
Current Drug Metabolism